Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Μ Opioid Receptor (MOR) Agonist/Δ Opioid Receptor (DOR) Antagonist Ligands
Journal of Medicinal Chemistry - United States
doi 10.1021/jm400050y
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2013
Authors
Publisher
American Chemical Society (ACS)